Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4836374> ?p ?o }
Showing triples 1 to 31 of
31
with 100 triples per page.
- Q4836374 subject Q7170959.
- Q4836374 abstract "BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia. Being a derivative of verapamil, it possesses the ability to inhibit Ca+2 membrane channels. Specific modifications in hydrogen bonding activity, nitrogen lone pair availability, and molecular flexibility allow BRL-32872 to inhibit K+ channels as well. As such, BRL-32872 is classified as both a class III (K+ blocking) and class IV (Ca+2 blocking) antiarrhythmic agent.".
- Q4836374 iupacName "N-(3,4-Dimethoxyphenyl)-N-(3-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}propyl)-4-nitrobenzamide".
- Q4836374 thumbnail BRL-32872.svg?width=300.
- Q4836374 wikiPageWikiLink Q105688.
- Q4836374 wikiPageWikiLink Q1410769.
- Q4836374 wikiPageWikiLink Q14865830.
- Q4836374 wikiPageWikiLink Q162908.
- Q4836374 wikiPageWikiLink Q169324.
- Q4836374 wikiPageWikiLink Q185089.
- Q4836374 wikiPageWikiLink Q188151.
- Q4836374 wikiPageWikiLink Q189331.
- Q4836374 wikiPageWikiLink Q194277.
- Q4836374 wikiPageWikiLink Q209583.
- Q4836374 wikiPageWikiLink Q217111.
- Q4836374 wikiPageWikiLink Q241549.
- Q4836374 wikiPageWikiLink Q408619.
- Q4836374 wikiPageWikiLink Q410291.
- Q4836374 wikiPageWikiLink Q420060.
- Q4836374 wikiPageWikiLink Q5038333.
- Q4836374 wikiPageWikiLink Q7170959.
- Q4836374 wikiPageWikiLink Q804644.
- Q4836374 iupacname "N--N--4-nitrobenzamide".
- Q4836374 type ChemicalCompound.
- Q4836374 type ChemicalSubstance.
- Q4836374 type ChemicalObject.
- Q4836374 type Thing.
- Q4836374 type Q11173.
- Q4836374 comment "BRL-32872 is an experimental drug candidate that provides a novel approach to the treatment of cardiac arrhythmia. Being a derivative of verapamil, it possesses the ability to inhibit Ca+2 membrane channels. Specific modifications in hydrogen bonding activity, nitrogen lone pair availability, and molecular flexibility allow BRL-32872 to inhibit K+ channels as well. As such, BRL-32872 is classified as both a class III (K+ blocking) and class IV (Ca+2 blocking) antiarrhythmic agent.".
- Q4836374 label "BRL-32872".
- Q4836374 depiction BRL-32872.svg.